There are 702 resources available
477P - Association of gastric background mucosa status with the efficacy of immune checkpoint inhibitors in patients with unresectable advanced gastric cancer
Presenter: Yuma Kamijo
Session: Poster Display session
479P - Survival outcomes of resected gastroesophageal cancer and impact of active surveillance: Experience from a tertiary centre
Presenter: Federico Longo Munoz
Session: Poster Display session
480P - Proportional correlation between systemic inflammation response index and time to gastric cancer recurrence
Presenter: Hee Seok Moon
Session: Poster Display session
481P - Gastric cancer with bone metastasis: Incidence, clinicopathological features, and influence on survival
Presenter: Anchal Mishra
Session: Poster Display session
482P - Blood-based oxidative phosphorylation-related gene signature and their SNPs as novel prognostic biomarkers for gastric cancer patients treated with nivolumab
Presenter: Chiaki Inagaki
Session: Poster Display session
483P - Germinal centre microarchitecture in tumour-negative lymph nodes after different neoadjuvant chemotherapy regimens in patients with oesophagogastric cancer: Results from the UK MRC OE05 trial
Presenter: Maximilian Kloft
Session: Poster Display session
484P - Clinical and biologic characteristic of gastro-esophageal cancers (GECs) harboring CLDN18::ARHGAP fusions
Presenter: Axel Grothey
Session: Poster Display session
485P - Heterogeneity and dynamic changes of PD-L1 expression and CPS score in patients with gastroesophageal malignancies
Presenter: Mohamed Salem
Session: Poster Display session
486P - Genomic profile differences between primary and recurrent tumors in curatively resected gastric cancer: The Liquid-GEAR study
Presenter: Hiroyuki Takeda
Session: Poster Display session
487P - HER2DX ERBB2 mRNA assay following trastuzumab-based chemotherapy in HER2-positive (HER2+) advanced gastric cancer (AGC)
Presenter: Tamara Sauri Nadal
Session: Poster Display session